C1ORF109 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.582200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.509400E-01
Normal-vs-Stage2
5.627200E-01
Normal-vs-Stage3
2.775100E-03
Normal-vs-Stage4
8.208800E-01
Stage1-vs-Stage2
3.738400E-01
Stage1-vs-Stage3
6.024200E-03
Stage1-vs-Stage4
8.491800E-01
Stage2-vs-Stage3
1.26140000000774E-06
Stage2-vs-Stage4
3.510600E-01
Stage3-vs-Stage4
3.485700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.678400E-01
Normal-vs-AfricanAmerican
9.638400E-01
Normal-vs-Asian
2.435600E-01
Caucasian-vs-AfricanAmerican
3.845400E-01
Caucasian-vs-Asian
2.501800E-01
AfricanAmerican-vs-Asian
1.645610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.039800E-01
Normal-vs-Female
6.394400E-01
Male-vs-Female
3.694200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.825800E-01
Normal-vs-Age(41-60Yrs)
8.077200E-01
Normal-vs-Age(61-80Yrs)
5.119400E-01
Normal-vs-Age(81-100Yrs)
1.637420E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.842800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.503000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.466400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.436100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.218300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.282000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.351800E-01
Normal-vs-Daily Drinker
2.338400E-01
Normal-vs-Weekly Drinker
5.413000E-01
Normal-vs-Occasional Drinker
6.844200E-01
Normal-vs-Social Drinker
8.601400E-01
Non Drinker-vs-Daily Drinker
8.494200E-01
Non Drinker-vs-Weekly Drinker
7.008000E-01
Non Drinker-vs-Occasional Drinker
1.503450E-01
Non Drinker-vs-Social Drinker
5.921900E-02
Daily Drinker-vs-Weekly Drinker
6.358200E-01
Daily Drinker-vs-Occasional Drinker
1.430970E-01
Daily Drinker-vs-Social Drinker
6.063900E-02
Weekly Drinker-vs-Occasional Drinker
5.149200E-01
Weekly Drinker-vs-Social Drinker
3.349200E-01
Occasional Drinker-vs-Social Drinker
6.602200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.982000E-01
Normal-vs-Grade 2
9.386600E-01
Normal-vs-Grade 3
9.324800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.910000E-01
Grade 1-vs-Grade 3
3.606600E-01
Grade 1-vs-Grade 4
9.982000E-01
Grade 2-vs-Grade 3
8.574000E-01
Grade 2-vs-Grade 4
9.386600E-01
Grade 3-vs-Grade 4
9.324800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.876430E-01
Normal-vs-NonDiabetic
4.584800E-01
Diabetic-vs-NonDiabetic
1.169990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.249000E-01
Normal-vs-NoPancreatitis
4.012800E-01
Pancreatitis-vs-NoPancreatitis
8.201600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.140600E-01
Normal-vs-N1
5.950600E-01
N0-vs-N1
6.166600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.162000E-01
Normal-vs-TP53-NonMutant
9.018000E-01
TP53-Mutant-vs-TP53-NonMutant
1.297170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
